Eye Imaging for the Study of Childhood Myopia

NCT ID: NCT07335146

Last Updated: 2026-01-14

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 100 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2026-01-31
• Study Completion Date: 2027-12-31

Brief Summary

Myopia (nearsightedness) is increasing worldwide and is becoming a serious public health problem. Studies estimate that by 2050, if no action is taken, almost half of the world's population will be myopic. About 10% of people could develop severe myopia, which increases the risk of serious eye problems such as retinal detachment, damage to the macula, or glaucoma.

Children are particularly affected because myopia often worsens as they grow. Several treatments are now available to slow the progression of myopia in children, but these treatments are not equally effective for everyone. Some children respond better than others, and the reasons for these differences are not yet well understood. One possible explanation is that differences in eye anatomy may influence the effectiveness of a treatment. This suggests that myopia treatments may need to be tailored to each child. By studying the anatomy of the eye, researchers could improve and personalize myopia control strategies.

The study entitled "Eye imaging for the study of childhood myopia" aims to better understand the structure of children's eyes. The study will collect clinical data, including images of the eye taken with MRI and measurements of the eye obtained using standard eye examination devices. The data will then be analyzed using image-processing and statistical methods to allow a detailed study of children's eye anatomy.

Conditions

Hyperopia and Myopia

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: BASIC_SCIENCE
• Blinding Strategy: NONE

Study Groups

MRI and ophthalmological measurements

All enrolled participants will undergo the same eye examinations such as head MRI and ophthalmological measurements

Group Type: EXPERIMENTAL

Ophtalmic measurements to estimate geometrical distances

Intervention Type: DEVICE

Patients will undergo routine ophthalmic examinations, such as ocular biometry to estimate axial length and corneal topography. Anatomical characteristics will then be derived from the geometric measurements obtained from each device. All measurements are non-invasive and non-ionizing. They all involve conventional ophthalmic devices that are widely used in clinical settings.

MRI

Intervention Type: DEVICE

Participants will undergo Magnetic Resonance Imaging (MRI) to image their eyes. A head antenna will be used. All measurements are non-invasive.

Ophtalmic measurements to measure wavefront aberrations

Intervention Type: DEVICE

Patients will undergo ophthalmic measurements to assess ocular wavefront aberrations. These measurements will be performed using commercially available devices that are widely accepted in routine clinical practice. All procedures are non-invasive and non-ionizing.

Interventions

Ophtalmic measurements to estimate geometrical distances

Patients will undergo routine ophthalmic examinations, such as ocular biometry to estimate axial length and corneal topography. Anatomical characteristics will then be derived from the geometric measurements obtained from each device. All measurements are non-invasive and non-ionizing. They all involve conventional ophthalmic devices that are widely used in clinical settings.

Intervention Type: DEVICE

MRI

Participants will undergo Magnetic Resonance Imaging (MRI) to image their eyes. A head antenna will be used. All measurements are non-invasive.

Intervention Type: DEVICE

Ophtalmic measurements to measure wavefront aberrations

Patients will undergo ophthalmic measurements to assess ocular wavefront aberrations. These measurements will be performed using commercially available devices that are widely accepted in routine clinical practice. All procedures are non-invasive and non-ionizing.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Spherical equivalent under cycloplegia greater -6.5 D and less than 2 D
• Beneficiary of social security
• Written consent from both holders of parental authority (or from one in case of exclusive parental authority)

Exclusion Criteria

• Declared neurological deficit, including history of epileptic pathology or sensory-motor coordination disorders, vestibular or cerebellar pathology (for example, balance disorders)
• Current or progressive pathology of the eyes or their appendages that may affect vision, other than myopia (examples: glaucoma, retinitis pigmentosa…)
• Declared aphakia or pseudophakia (intraocular implant)
• Ocular motility problem such as strabismus or nystagmus
• Contraindication to MRI (claustrophobia, implanted devices such as pacemaker, etc.)

• Minimum Eligible Age: 6 Years
• Maximum Eligible Age: 12 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Essilor International

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Hôpital Fondation Adolphe de Rothschild

Paris, , France

Countries

France

Central Contacts

Julien Savatosky, Doctor

Role: CONTACT

jsavatovsky@for.paris

00331 48 03 69 30

Facility Contacts

Julien Savatovsky, Doctor

Role: primary

jsavatovsky@for.paris

00331 48 03 69 30

Other Identifiers

2025-A00844-45

Identifier Type: REGISTRY

Identifier Source: secondary_id

WS10445

Identifier Type: -

Identifier Source: org_study_id